Evidence map›Paper›PMID 42549366›Full record

ArticleFujita medical journal2026

Evaluation of renal function in a patient with terminal rectal cancer who developed morphine hydrochloride-induced respiratory depression.

Yoshihiro Uekuzu, Masanobu Usui, Akihiko Futamura, Takahiko Inagaki

Abstract read
In one paragraph

Article in Fujita medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yoshihiro UekuzuDepartment of Pharmacy, Fujita Health University Okazaki Medical Center, Okazaki, Aichi, Japan.
Masanobu UsuiDepartment of Surgery and Palliative Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Akihiko FutamuraDepartment of Surgery and Palliative Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Takahiko InagakiDepartment of Pharmacy, Fujita Health University Okazaki Medical Center, Okazaki, Aichi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A challenge in patients with terminal cancer is that serum creatinine-based estimates of renal function often deviate from true renal function because cachexia-related loss of muscle mass leads to abnormally low serum creatinine levels. Serum cystatin C is a useful marker of renal function in patients with decreased muscle mass; however, there are limited data on its use in patients with terminal cancer. In this study, we present a detailed assessment of renal function, incorporating muscle mass measurement by bioelectrical impedance analysis, in a patient with terminal rectal cancer who developed respiratory depression while receiving a stable dose of morphine hydrochloride injections.

Indexed as

eGFRMorphineSarcopeniaSerum cystatin CTerminal cancer patient

Identifiers

PMID42549366
PMCPMC13433044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.